<Anchor>

In the midst of this, it was reported that the United States was swept away by the three months of Remdesibir, the only approved drug for corona19. Although the pharmaceutical company itself is an American company, critics say it is unprecedented as patients in other countries have become unable to use medicine for the time being.

This is Correspondent Correspondent Kim Yun-soo of Washington.

<Reporter> The

U.S. Department of Health and Human Services released a press release stating that it had secured a large amount of Remedyvir, a Corona 19 treatment.

It said that it secured 100% of production in July and 90% of production in August and September.

In fact, it was a three-month sweep.

US Secretary of Health and Welfare Eiza says President Trump has set an amazing contract to give Americans access to Corona's first approved treatment.

Remedyvir is the only Corona19 treatment approved by the U.S. Food and Drug Administration for emergency use, and the initial clinical trials showed a 31% reduction in patient recovery.

The World Health Organization immediately expressed concern over the sweeping news of the United States.

[Ryan/WHO Deputy Secretary: There are many patients suffering from corona19 worldwide. We want everyone to have access to this medicine to save their lives.] In

particular, patients from other countries have also participated in the clinical trial of the remedyvir.

[Hill/Senior Researcher, University of Liverpool, UK (Source: Twitter): It should be remembered that patients in Corona19, UK, also participated in clinical trials and demonstrated that the drug worked. Equity between nations must be balanced.] The

European Union has also announced that it will continue to secure sufficient supplies for EU member states, and the competition to secure the Remdesivir is expected to intensify worldwide.